J. M. Green, Serum screening for Down's syndrome: experiences of obstetricians in England and Wales, BMJ, vol.309, issue.6957, pp.769-72, 1994.
DOI : 10.1136/bmj.309.6957.769

C. Opinion and N. , Opinion on the detection of the risk of foetal trisomy 21 by blood tests in pregnant women

. France, Decree No. 95-559 of 6 May 1995 concerning cytogenetic and biological analysis used for prenatal diagnosis in utero, Journal official, vol.108, 1995.

. France, Order of 30 september 1997 on the consent of pregnant women to the carrying out of the analyses referred to in article r. 162-16-1 of the public Health Code, Journal official n°31, pp.15820-15821, 1997.

. France, Order of 11 february 1999 modifying the order of 3 april 1985 establishing the Nomenclature for biological analysis

J. Gekas, J. Gondry, S. Mazur, P. Cesbron, and F. Thepot, Informed consent to serum screening for Down syndrome: are women given adequate information?, Prenatal Diagnosis, vol.297, issue.5
DOI : 10.1002/(SICI)1097-0223(199901)19:1<1::AID-PD456>3.0.CO;2-S

D. K. Smith, R. W. Shaw, and T. M. Marteau, Informed consent to undergo serum screening for Down's syndrome: the gap between policy and practice, BMJ, vol.309, issue.6957, pp.776-783, 1994.
DOI : 10.1136/bmj.309.6957.776

S. Michie, E. Dormandy, and T. M. Marteau, Informed choice: understanding knowledge in the context of screening uptake, Patient Education and Counseling, vol.50, issue.3, pp.247-253, 2003.
DOI : 10.1016/S0738-3991(03)00044-2

T. M. Marteau, E. Dormandy, and S. Michie, A measure of informed choice, Health Expectations, vol.55, issue.2, pp.99-108, 2001.
DOI : 10.1080/09540129550126722

S. Michie, E. Dormandy, and T. M. Marteau, The multi-dimensional measure of informed choice: a validation study, Patient Education and Counseling, vol.48, issue.1, pp.87-91, 2002.
DOI : 10.1016/S0738-3991(02)00089-7

S. Michie, D. Smith, and T. M. Marteau, Prenatal tests: how are women deciding?, Prenatal Diagnosis, vol.3, issue.8, pp.743-791, 1999.
DOI : 10.1002/(SICI)1097-0223(199908)19:8<743::AID-PD636>3.0.CO;2-C

R. Harris, B. Lane, H. Harris, P. Williamson, J. Dodge et al., National Confidential Enquiry into counselling for genetic disorders by non-geneticists: general recommendations and specific standards for improving care, BJOG: An International Journal of Obstetrics and Gynaecology, vol.36, issue.6, pp.658-663, 1999.
DOI : 10.1016/0268-960X(87)90032-4

B. Lane, K. Challen, H. J. Harris, and R. Harris, Existence and quality of written antenatal screening policies in the United Kingdom: postal survey, BMJ, vol.322, issue.7277, pp.22-25, 2001.
DOI : 10.1136/bmj.322.7277.22

M. Sadler, Serum screening for Down's syndrome: how much do health professionals know?, BJOG: An International Journal of Obstetrics and Gynaecology, vol.311, issue.2, pp.176-179, 1997.
DOI : 10.1016/S0033-3506(05)80018-6

E. Dormandy and T. M. Marteau, Uptake of a prenatal screening test: the role of healthcare professionals' attitudes towards the test, Prenatal Diagnosis, vol.22, issue.11, pp.864-868, 2004.
DOI : 10.1002/pd.1028

V. Goel, R. Glazier, S. Holzapfel, P. Pugh, and A. Summers, EVALUATING PATIENT'S KNOWLEDGE OF MATERNAL SERUM SCREENING, Prenatal Diagnosis, vol.297, issue.5, pp.425-455, 1996.
DOI : 10.1002/(SICI)1097-0223(199605)16:5<425::AID-PD874>3.0.CO;2-2

R. Favre, Screening for Down syndrome. Was informed consent realized? ]. DEA in Biological Sciences and Medical Ethics, Deontology and Medical Responsibility
URL : https://hal.archives-ouvertes.fr/inserm-00126553

C. H. Braddock, S. D. Fihn, W. Levinson, A. R. Jonsen, and R. A. Pearlman, How doctors and patients discuss routine clinical decisions): 339. 1. How old are you? ____________ 2. What is your level of education? No high-school diploma ? High-school diploma ? at least 2 years of further education after high school 3. What is your first language?, J. Gen. Intern. Med, vol.12, issue.6, 1997.
DOI : 10.1046/j.1525-1497.1997.00057.x
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1497128